Tibet Aim Pharm., Inc. engages in the research and development, production, and sale of chemical drugs, and Chinese medicines. Its products include miglitol tablets, gualoupi injections, nalmefene hydrochloride injections, carbetocin injections, hongjin xiaojie tablets, and aceclofenac enteric-coated tablets. The company was founded on December 29, 2007 and is headquartered in Chengdu, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company